- CLINICAL PROFESSOR | Medicine, Gastroenterology
- Hospital Affiliation
- The Mount Sinai Hospital
Dr. Sachar was an honors graduate of Harvard College and Harvard Medical School. While working as a research associate with the U.S. Public Health Service in Bangladesh, Dr. Sachar played a role in the development of oral rehydration therapy for cholera and other diarrheal diseases, an advance credited with saving millions of lives each year.
After completing his medical residency at Boston's Beth Israel Hospital and his GI Fellowship at The Mount Sinai Hospital, he went on to become a specialist in inflammatory bowel disease, a field in which he has over 200 publications. He chaired the Research Development Committee of the Crohn's and Colitis Foundation of America, served on the Foundation's National Scientific Advisory Committee, and was the recipient of its Distinguished Service Award in 1991. A founding director of the Burrill B. Crohn Research Foundation, he is also the first American to have been elected Chairman of the International Organization for the Study of Inflammatory Bowel Disease. In 2002, Dr. Sachar was elected a Master of the American College of Gastroenterology and in 2005 he was named a Fellow of the American Gastroenterological Association. From 2005-2008, he served as Chairman of the GI Drugs Advisory Panel of the FDA.
As the first chairman of the American Gastroenterological Association's Clinical Teaching Project, he developed new resources and set new standards for clinical teaching nationwide. His teaching activities have earned him the 1996 Distinguished Educator Award of the AGA; the 1989 Baker Presidential Lectureship of the American College of Gastroenterology; the Norman Tanner Gold Medal of St. George's Hospital Medical School in London; the K.H. Koster Memorial Lectureship of the Danish Society of Gastroenterology; the Nana Svartz Lecture of the Swedish Society of Gastroenterology; and other International State-of-the Art Lectures on the topic of inflammatory bowel disease in Belgium, Spain, Portugal, Switzerland, France, Germany, Sweden, Italy, Austria, England, Greece, Turkey, Hungary, Poland, Romania, Israel, India, Hong Kong and Russia.
At Mount Sinai, Dr. Sachar has received the 1975 and 1978 Faculty Awards for Excellence in Teaching, the 1984 annual Distinguished Teacher Award of the Department of Medicine, the 1987 Solomon A. Berson Award as the department's outstanding physician and teacher, the Jacobi Medallion for outstanding contributions to medicine in 1994, the Alexander Richman Commemorative Award for Humanism in Medicine in 1996, and in 1997 the "Gold-Headed Cane," Mount Sinai's highest award for the physician "best exemplifying the ideals of the profession." Mount Sinai has recognized Dr. Sachar's many years of service to the institution and the profession by permanently endowing an annual "Joanna and David B. Sachar, M.D., Internal Award and Visiting Professorship in Inflammatory Bowel Diseases" in his honor.
- Crohn's Disease
- Inflammatory Bowel Disease
- Ulcerative Colitis
Greenstein AJ, Sachar DB, Panday AK, Dikman SH, Meyers S, Heimann T , Gumaste V, Werther J, Janowitz HD. Amyloidosis and Inflammatory Bowel Disease: A 50-Year Experience with 25 Patients. Medicine 1992; 71: 261-270.
Greenstein AJ, Mullin GE, Strauchen JA, Heimann T , Janowitz HD, Aufses Jr AH, Sachar DB. Lymphoma in Inflammatory Bowel Disease. Cancer 1992; 69: 1119-1123.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Below are financial relationships with industry reported by Dr. Sachar during 2017 and/or 2018. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
- CDx Laboratories, Inc.
- Gerson Lehrman Group
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.